Compare BIO & VFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIO | VFS |
|---|---|---|
| Founded | 1952 | 2017 |
| Country | United States | Vietnam |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Blank Checks |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 7.9B |
| IPO Year | N/A | N/A |
| Metric | BIO | VFS |
|---|---|---|
| Price | $300.28 | $3.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $358.50 | $5.83 |
| AVG Volume (30 Days) | 170.4K | ★ 532.4K |
| Earning Date | 10-29-2025 | 11-21-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,557,500,000.00 | $2,554,394,588.00 |
| Revenue This Year | $1.77 | N/A |
| Revenue Next Year | $2.30 | $43.19 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 81.20 |
| 52 Week Low | $211.43 | $2.56 |
| 52 Week High | $373.69 | $4.65 |
| Indicator | BIO | VFS |
|---|---|---|
| Relative Strength Index (RSI) | 39.06 | 55.49 |
| Support Level | $298.02 | $3.34 |
| Resistance Level | $307.78 | $3.67 |
| Average True Range (ATR) | 8.35 | 0.11 |
| MACD | -2.13 | 0.01 |
| Stochastic Oscillator | 16.30 | 47.64 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
VinFast Auto Ltd manufactures cars, and motor vehicles, renders leasing activities, trades smartphones, and related businesses. The company is engaged in designing and manufacturing premium EVs, e-scooters, and e-buses. The company's initial EV product line is an all-new range of fully electric A- through E-segment SUVs. The Company has three reportable segments, namely Car, E-scooter and Ebus. The Car segment includes the design, development, manufacturing and sales of cars and related battery lease and battery charging services for cars. The E-scooter segment includes the design, development, manufacturing and sales of e-scooters and related battery lease and battery charging service for e-scooters. The Ebus segment includes the design, development, manufacturing and sales of Ebus.